In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...
Researchers have uncovered a previously unrecognized role for immune cell surface sugars in driving inflammation in psoriasis. Scientists have refined how they understand the role of sugars called ...
Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...
Everyday Health on MSN
Is that rash psoriasis, or is it something else?
From white blisters to red and scaly patches, psoriasis skin rashes come in several different forms. How do you know if you have psoriasis or a similar-looking skin condition?
A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and ...
Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...
Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong ...
Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial ...
In this MedPage Today video segment, Linda Stein Gold, MD, director of dermatology clinical research at the Henry Ford Health System in Detroit, discusses the promise of TYK2 inhibitors and an oral ...
Newspoint on MSN
Who gets psoriasis and how to avoid it?
Psoriasis is a serious skin disease caused by a weakened immune system. It causes red, scaly patches to form on the skin. It ...
Patients with moderate-to-severe plaque psoriasis who took the once-daily pill showed significantly clearer skin compared with those on placebo or the existing therapy apremilast, the company said.
Ever feel like the Kardashians live behind a permanent filter? It’s easy to think they wake up with full lashes and contour, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback